Tag: identification

CORAL GABLES, Fla., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced the National Comprehensive Cancer Network^® (NCCN) Clinical Practice Guidelines in Oncology (NCCN Guidelines^®) for Small Cell Lung Cancer (SCLC) now include new additions involving Lambert Eaton myasthenic syndrome (LEMS), amifampridine (FIRDAPSE^®), and the tests for PQ- and N-type voltage-gated calcium channel (VGCC) antibodies.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA, SOUTH AFRICA, NEW ZEALAND, JAPAN OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL 

BEIJING, Aug. 05, 2025 (GLOBE NEWSWIRE) -- The "Symposium on International Cooperation for Digital Product Passport (DPP) and International Standards for Entire Lifecycle Management," organized by Zhongguancun Industry & Information Research Institute of Two-Dimensional Code Technology (ZIIOT), International Identification Code Industry Alliance (ICA), and the IEC 63538 Working Group, concluded successfully in Beijing. It unveiled the groundbreaking MA-DPP Universal Framework V1.0, an open international public good, providing standardized solutions for global supply chain digital transformation while seeking worldwide partners for joint implementation to facilitate smooth and stable global supply chains.

/Translation from Lithuanian/

Press Release